COMMUNIQUÉS West-GlobeNewswire

IBA lance CASSY®, un nouveau module compact de radiochimie pour améliorer l'efficacité de la production de radiopharmaceutiques
13/05/2025
Louvain-la-Neuve, Belgique, le 13 mai 2025 – IBA (Ion Beam Applications S.A., EURONEXT), le leader mondial des technologies d’accélération de particules et le principal fournisseur de solutions de production de [...]
NMD Pharma to present compelling preclinical data highlighting the potential of ClC-1 ion channel inhibition to improve disease symptoms and progression in MuSK myasthenia gravis at the MGFA International Conference on Myasthenia and Relate
13/05/2025
NMD Pharma to present compelling preclinical data highlighting the potential of ClC-1 ion channel inhibition to improve disease symptoms and progression in MuSK myasthenia gravis at the MGFA International Conference on [...]
Arialief Reviews and Complaints 2025: What Science Says About This Neuropathy Relief Supplement (EXPOSED)
13/05/2025
FINDLAY, Ohio, May 13, 2025 (GLOBE NEWSWIRE) -- For years, I've explored every avenue for neuropathy relief—countless supplements, treatments promising quick fixes, and prescriptions that often left me disappointed. [...]
Why PhenQ Is Touted as the Best Belly Fat Burner for Men in 2025
13/05/2025
New York City, May 13, 2025 (GLOBE NEWSWIRE) -- One of the major concerns among aging men nowadays is the accumulation of excess belly fat. It’s not only unattractive and signals the fading of youth, but it could also [...]
TestoPrime Redefines Natural Vitality: The Testosterone Booster Men Trust in 2025
13/05/2025
Glasgow, May 13, 2025 (GLOBE NEWSWIRE) -- Are you noticing the days are starting to seem longer, yet secretly worrying that your tiredness is really taking the toll on you because your endurance isn’t what it used to be [...]
Best Metabolism Booster Supplement for Women and Men for Weight Loss - Top Pills and Supplements to Boost Metabolism to Lose Weight - Wolfson Brands
13/05/2025
Glasgow, May 12, 2025 (GLOBE NEWSWIRE) -- Metabolism plays a significant role in weight loss. That's why all the top weight loss supplements are also metabolism boosters. Metabolism booster supplements are designed to [...]
EnGeneIC launches groundbreaking new Australian trial for innovative cancer therapy, with international trial site in Singapore to follow
13/05/2025
First Patient dosed in Phase I/IIa Basket Trial for Solid Tumours at Mater Hospital, North Sydney Recruitment to open this month at Frankston Hospital, Victoria Further site to follow at Curie Oncology, Singapore SYDNEY [...]
Coastland Dental Introduces Advanced Dental Technology to Enhance Patient Experiences in Burbank
13/05/2025
Burbank, CA, May 12, 2025 (GLOBE NEWSWIRE) -- Coastland Dental, a leading dental practice in Burbank, is introducing advanced dental technologies to make dental care more comfortable, efficient, and personalized for [...]
Catheter Precision, Inc. Announces $1.5 Million Private Placement Equity Financing and Potential Strategic Alliance
13/05/2025
Fort Mill, S.C., May 12, 2025 (GLOBE NEWSWIRE) -- Catheter Precision (VTAK - NYSE/American), a US based medical device company focused on developing technologically advanced products for the cardiac electrophysiology [...]
ANI Pharmaceuticals to Participate at the H.C. Wainwright 3rd Annual BioConnect Conference at NASDAQ
13/05/2025
PRINCETON, N.J., May 12, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, and Stephen Carey, Chief Financial Officer, [...]
Scientific Industries to Host First Quarter Fiscal Year 2025 Financial Results Investor Call on May 14, 2025
12/05/2025
Investor Call to be held at 11:00 AM Eastern Time BOHEMIA, N.Y., May 12, 2025 (GLOBE NEWSWIRE) -- Scientific Industries, Inc. (OTCQB: SCND), a life sciences tool provider, and a developer of digitally simplified [...]
Apimeds Pharmaceuticals US, Inc. Announces Closing of Initial Public Offering
12/05/2025
Hopewell, New Jersey, May 12, 2025 (GLOBE NEWSWIRE) -- Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) (“Apimeds” or the “Company”), a clinical stage biopharmaceutical company that is in the process of developing [...]
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
12/05/2025
BEDFORD, Mass., May 12, 2025 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global leader in the osteoarthritis (“OA”) pain management and regenerative solutions spaces focused on early intervention [...]
Quipt Home Medical Reports Fiscal Second Quarter 2025 Results
12/05/2025
Posts Strong Adjusted EBITDA of 23.3% of Revenue CINCINNATI, May 12, 2025 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (“ Quipt ” or the “ Company ”) (NASDAQ: QIPT; TSX: QIPT), a U.S. based home medical equipment [...]
New 4-Year Data Shows Sustained Response to TransCon® PTH (Palopegteriparatide) Therapy in Adults with Hypoparathyroidism
12/05/2025
COPENHAGEN, Denmark, May 12, 2025 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced new data from Week 214 of its Phase 2 PaTH Forward Trial showing that long-term treatment with TransCon PTH ( [...]
Context Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
12/05/2025
PHILADELPHIA, May 12, 2025 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“Context” or the “Company”) (Nasdaq: CNTX), a clinical-stage biopharmaceutical company advancing T cell engaging bispecific antibodies for solid [...]
ZyVersa Therapeutics Reports First Quarter 2025 Financial Results and Highlights Pipeline Progress
12/05/2025
KEY HIGHLIGHTS First patient expected to start therapy by end of Q2-2025 in Phase 2a proof-of concept clinical trial for Cholesterol Efflux Mediator TM VAR 200 in patients with diabetic kidney disease (DKD). Obesity- [...]
BeyondSpring Reports First‑Quarter 2025 Financial Results and Provides Corporate Update
12/05/2025
Presentation at IO 360° conference showed early efficacy for Plinabulin combinations in metastatic NSCLC and Hodgkin lymphoma resistant to PD‑1/L1 therapy SEED’s first‑in‑class RBM39 degrader, reported at AACR 2025 for [...]
Tonix Pharmaceuticals Reports First Quarter 2025 Financial Results and Operational Highlights
12/05/2025
FDA PDUFA goal date of August 15, 2025, for TNX-102 SL for the management of fibromyalgia; if approved, TNX-102 SL would become the first new drug for treating fibromyalgia in more than 15 years Announced positive [...]

Pages